Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received October 30, 2018
- Accepted April 29, 2019
- Published online May 17, 2019.
Article Versions
- You are currently viewing a previous version of this article (May 17, 2019 - 05:08).
- View the most recent version of this article
Copyright & Usage
Copyright © 2019, Parenteral Drug Association
Author Information
- John Mattila1 (john.mattila{at}regeneron.com),
- Sherrie Curtis2 (curtis.sherrie{at}gene.com),
- Yenny Webb-Vargas2,
- Eileen Wilson3 (eileen.wilson{at}gsk.com),
- Olga Galperina3 (olga.x.galperina{at}gsk.com),
- David Roush4 (david.roush{at}merck.com),
- Scott Tobler4 (scott_tobler{at}merck.com),
- Bradford Stanley5 (brad.stanley{at}biogen.com),
- Mike Clark6 (michael.clark{at}abbvie.com),
- Justin Weaver7 (justin.weaver{at}alexion.com),
- Jeremy Pike7 (jeremy.pike{at}alexion.com),
- Deqiang Yu8 (deqiang.yu{at}bms.com),
- Xinfang Li9 (xinfang.li{at}mabplex.com),
- Andreas Flicker10 (andreas.flicker{at}shire.com),
- Johanna Kindermann10 (johanna.kindermann{at}shire.com),
- Norbert Schuelke11 (norbert.schuelke{at}takeda.com),
- Richard Whitcombe12 (richard.whitcombe{at}ucb.com) and
- Louise Bennett13,14 (bennettl{at}biophorum.com)
- 1 Regeneron Pharmaceuticals Inc.;
- 2 Genentech Inc;
- 3 GSK plc;
- 4 Merck & Co Inc;
- 5 Biogen;
- 6 AbbVie;
- 7 Alexion Pharmaceuticals Inc;
- 8 Bristol Meyers Squibb;
- 9 MabPlex;
- 10 Shire plc;
- 11 Takeda Pharmaceuticals International Co;
- 12 UCB;
- 13 BioPhorum
- ↵* Corresponding author; email: bennettl{at}biophorum.com
